Blood
Publisher: Elsevier · ISSN 0006-4971 · 65 articles
- Central nervous system graft-versus-host disease pathophysiology: mechanistic pathways and therapeutic targets
- Immunologic & Plasma-Dependent Mechanisms of Chronic Hemolysis and Hyperhemolysis in Sickle Cell Disease
- Thrombin-mediated AutoRegulation of FVIII-mimetic antibodies enabling dynamic control of the hemostatic response
- Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific Antibody
- Regenerative Stress Contributes to Higher Clonal Hematopoiesis with Myelodysplastic Features in Sickle Cell Disease Mice
- Microbiota-derived short-chain fatty acids control cGVHD development by regulating antibody production
- Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial
- Initial fixed low-versus moderate-dose hydroxyurea assignment in the long-term follow-up of the SPRINT cohort
- Molecular Underpinnings and Prevalence of Donor Cell–Derived Hematologic Neoplasms among Spanish Transplantation Centers
- Evolving Paradigms in Hematology: Splicing Factor Mutations in Myeloid Malignancies
- Peginterferon alfa-2a, bictegravir–emtricitabine–tenofovir alafenamide, and venetoclax in adult T-cell leukemia/lymphoma
- Multi-omics reveals evolution from CD7-negative T cell dysregulation to EBV-positive LPD after CD7 CAR-T therapy
- Low Incidence of Cryptic Genetic Marrow Failure in Pediatric Severe Aplastic Anemia Following Negative Clinical Workup
- Identifying novel genomic alterations in relapsed childhood B-ALL: a report from the Children’s Oncology Group
- Less is more: expanding human HSCs via a novel mimetic niche
- Prime advantage: making T cells drug resistant
- MRD is a journey, not a snapshot
- Epigenetically activating T cells to attack AML
- A kindlin splice for stressful times
- Chasing the Aurora: naturally occurring prothrombotic FVIII
- Don’t rush it: early CNI exposure derails tolerance
- Combining quizartinib with intensive chemotherapy for older patients with newly diagnosed AML: results of the UK NCRI AML18 trial
- Expansion of functional human long-term HSCs through restraining excessive cell cycle activation
- Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression
- MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma
- Boosting antileukemia cytotoxicity of CD4 and CD8 T cells through combined inhibition of MEK and HDAC
- FERMT3 alternative splicing enhances kindlin-3 membrane recruitment for neutrophil adhesion during stress myelopoiesis
- Factor VIII Aurora: a naturally occurring gain-of-function FVIII variant with enhanced FIXa affinity
- Early administration of calcineurin inhibitors limits the tolerogenic effect of PTCy in allogeneic hematopoietic transplant
- Choi HR, Piao H, Atriardi SR, et al. Selective depletion of ABO-responsive B cells by T-cell–engaging bispecific antibody conjugates for ABOi transplantation. Blood. 2026;147(17):1928-1940.